Skip to main content

Table 3 Mean cumulative cisplatin doses

From: Ototoxicity evaluation in medulloblastoma patients treated with involved field boost using intensity-modulated radiation therapy (IMRT): a retrospective review

Cisplatin dose (mg/m2)

Frequence

%

% accumulated

0

9

22%

22%

270

6

14.6%

36.6%

300

3

7.3%

43.9%

315

1

2.4%

46.3%

360

3

7.3%

53.7%

390

1

2.4%

56.1%

420

1

2.4%

58.5%

425

1

2.4%

61.0%

450

11

26.8%

87.8%

495

1

2.4%

90.2%

540

1

2.4%

92.7%

600

3

7.3%

100%

Total

41

100%